| Affiliation: | 1. Dalhousie University, Department of Microbiology and Immunology, Halifax, NS B3K 6R8, Canada;2. Lab. Bio-PeroxIL EA7270, University of Bourgogne Franche-Comté, 6 Bd Gabriel, 21000 Dijon, France;3. Institute of Molecular Health Sciences, Swiss Federal Institute of Technology in Zurich (ETH Zürich), Zurich, Switzerland;4. Cell Biology Program, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, ON, Canada;5. Department of Biochemistry, University of Toronto, Toronto, ON, Canada;6. Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, South Korea;7. University of Alberta, Department of Cell Biology, Edmonton, AB T6G 2H7, Canada;1. Department of Radiation Oncology, Inselspital, Bern University Hospital, Freiburgstrasse 8, 3008 Bern, Switzerland;2. Department for BioMedical Research, Radiation Oncology, University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland;1. Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center LUMC, 2333, ZC, Leiden, The Netherlands;1. School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;2. Cell Architecture Research Center, Huazhong University of Science and Technology, Wuhan, China;1. Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK;2. Department of Chemical Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, ridge, MA, USA;3. Department of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands;1. Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima 770-8502, Japan;2. Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan;3. Diabetic Neuropathy Project, Department of Diseases and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan |
